The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

As the U.S. stock market faces heightened volatility amid escalating trade tensions and economic uncertainty, major indices like the Dow Jones and Nasdaq have entered correction and bear market ...

The acquisition also advances Lantheus’ capabilities with the addition of Evergreen’s radioligand therapy manufacturing infrastructure, including a revenue-generating CDMO business. “ ...

The Merger Agreement was approved by the Boards of Directors of both companies (other than by Dr. Gerard Bér, who is a director of both Lantheus and Evergreen, and by Heinz Mäusli, who is a ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical industry, announced today the completion of its acquisition of Evergreen Theragnostics, Inc., a ...

The acquisition also advances Lantheus’ capabilities with the addition of Evergreen’s radioligand therapy manufacturing infrastructure, including a revenue-generating CDMO business. “Today marks a ...